These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4080104)

  • 1. Fetal methylazoxymethanol acetate-induced lesions cause reductions in dopamine receptor-mediated catalepsy and stereotypy.
    Sanberg PR; Pevsner J; Autuono PG; Coyle JT
    Neuropharmacology; 1985 Nov; 24(11):1057-62. PubMed ID: 4080104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of fetal methylazoxymethanol acetate lesion on the synaptic neurochemistry of the adult rat striatum.
    Beaulieu M; Coyle JT
    J Neurochem; 1981 Oct; 37(4):878-87. PubMed ID: 6119358
    [No Abstract]   [Full Text] [Related]  

  • 3. Methylazoxymethanol (MAM)-induced brain lesion and oral dyskinesia in rats.
    Johansson P
    Psychopharmacology (Berl); 1990; 100(1):72-6. PubMed ID: 2296629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dextromethorphan on dopamine dependent behaviours in rats.
    Gaikwad RV; Gaonkar RK; Jadhav SA; Thorat VM; Jadhav JH; Balsara JJ
    Indian J Exp Biol; 2007 Aug; 45(8):712-9. PubMed ID: 17877148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological and neurochemical effects of fetal treatment with methylazoxymethanol on rat neocortex in adulthood.
    Johnston MV; Coyle JT
    Brain Res; 1979 Jul; 170(1):135-55. PubMed ID: 37983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depletion of cholinergic habenulo-interpeduncular neurons by selectively timed methylazoxymethanol acetate (MAM) treatment during pregnancy.
    Virgili M; Barnabei O; Contestabile A
    Brain Res; 1988 Sep; 460(2):361-5. PubMed ID: 3224267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal methylazoxymethanol treatment potentiates d-amphetamine- and methylphenidate-induced motor activity in male and female rats.
    Archer T; Fredriksson A; Sundström E; Luthman J; Lewander T; Söderberg U; Jonsson G
    Pharmacol Toxicol; 1988 Oct; 63(4):233-9. PubMed ID: 3194344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nocturnal hyperactivity induced by prenatal methylazoxymethanol administration as measured in a computerized residential maze.
    Balduini W; Lombardelli G; Peruzzi G; Cattabeni F; Elsner J
    Neurotoxicol Teratol; 1989; 11(4):339-43. PubMed ID: 2796888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Papaverine, drug-induced stereotypy and catalepsy and biogenic amines in the brain of the rat.
    Kostowski W; Gajewska S; Bidzinski A; Hauptman M
    Pharmacol Biochem Behav; 1976 Jul; 5(1):15-7. PubMed ID: 1033561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotransmitter chemistry of lissencephalic cortex induced in ferrets by fetal treatment with methylazoxymethanol acetate.
    Johnston MV; Haddad R; Carman-Young A; Coyle JT
    Brain Res; 1982 Jul; 256(3):285-91. PubMed ID: 6125249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrastriatal injection of kainic acid prevents the development of postsynaptic dopamine receptor hypersensitivity after chronic haloperidol treatment.
    Zarkovsky AM; Nurk AM; Rägo LK; Allikmets LH
    Neuropharmacology; 1982 Feb; 21(2):155-8. PubMed ID: 7199630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Action of fibrinopeptides A and B on the central dopaminergic system of rats pretreated with indomethacin.
    Swiderska D; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1986; 38(1):21-8. PubMed ID: 3763484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic evaluation of dopaminergic receptor blockade by metoclopramide.
    Hassan MN; Reches A; Kuhn C; Higgins D; Fahn S
    Clin Neuropharmacol; 1986; 9(1):71-8. PubMed ID: 3829008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of fetal treatment with methylazoxymethanol acetate at various gestational dates on the neurochemistry of the adult neocortex of the rat.
    Johnston MV; Carman AB; Coyle JT
    J Neurochem; 1981 Jan; 36(1):124-8. PubMed ID: 6109753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the participation of the dopaminergic transmission system in the effects of two newly synthesized barbiturates.
    Getova D; Markovska V
    Acta Physiol Pharmacol Bulg; 1988; 14(2):56-62. PubMed ID: 2851915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of buspirone on dopamine dependent behaviours in rats.
    Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ
    Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of naloxone on methamphetamine and apomorphine stereotypy and on haloperidol catalepsy in rats.
    Balsara JJ; Nandal NV; Burte NP; Jadhav JH; Chandorkar AG
    Psychopharmacology (Berl); 1984; 82(3):237-40. PubMed ID: 6425907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dihydroergotoxine on some dopamine-related behaviors in rats.
    Flório JC; Palermo-Neto J
    Gen Pharmacol; 1990; 21(4):411-5. PubMed ID: 2379797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical modulation of striatal function.
    Scatton B; Worms P; Lloyd KG; Bartholini G
    Brain Res; 1982 Jan; 232(2):331-43. PubMed ID: 6200179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral and biochemical changes after bilateral electrolytic lesions of the red nucleus of rat.
    Kolasa K; Consolo S; Costi P; Kleinrok Z; Zecca L
    Pharmacol Biochem Behav; 1995 May; 51(1):29-35. PubMed ID: 7617729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.